[go: up one dir, main page]

WO2006032464A3 - Method of treatment of acute exudative skin lesions and composition useful therefor - Google Patents

Method of treatment of acute exudative skin lesions and composition useful therefor Download PDF

Info

Publication number
WO2006032464A3
WO2006032464A3 PCT/EP2005/010151 EP2005010151W WO2006032464A3 WO 2006032464 A3 WO2006032464 A3 WO 2006032464A3 EP 2005010151 W EP2005010151 W EP 2005010151W WO 2006032464 A3 WO2006032464 A3 WO 2006032464A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin
treatment
skin lesions
composition useful
acute exudative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2005/010151
Other languages
French (fr)
Other versions
WO2006032464A2 (en
Inventor
Frederico Graf
Phillip Grob
Suzanne Gonser
Wolfgang Thuerlimann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medinova AG
Original Assignee
Medinova AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinova AG filed Critical Medinova AG
Publication of WO2006032464A2 publication Critical patent/WO2006032464A2/en
Publication of WO2006032464A3 publication Critical patent/WO2006032464A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention refers to the use of zinc oxide as unique pharmacologically active ingredient, in combination with a pharmaceutically acceptable hydrophilic vehicle, for the preparation of a pharmaceutical composition dedicated to the topical treatment of edges of chronic wounds and/or acute exudative skin lesions caused by intertrigo, decubitus, ulcus cruris, wet eczema, skin maceration, skin fissuring or skin photo damaging. The invention also provides a pharmaceutical composition comprising zinc oxide as unique pharmacologically active ingredient, in combination with a pharmaceutically acceptable hydrophilic vehicle.
PCT/EP2005/010151 2004-09-24 2005-09-20 Method of treatment of acute exudative skin lesions and composition useful therefor Ceased WO2006032464A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04022807.4 2004-09-24
EP04022807 2004-09-24

Publications (2)

Publication Number Publication Date
WO2006032464A2 WO2006032464A2 (en) 2006-03-30
WO2006032464A3 true WO2006032464A3 (en) 2006-10-26

Family

ID=34926703

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/010151 Ceased WO2006032464A2 (en) 2004-09-24 2005-09-20 Method of treatment of acute exudative skin lesions and composition useful therefor

Country Status (1)

Country Link
WO (1) WO2006032464A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512978A (en) * 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
DE4232143A1 (en) * 1992-09-25 1994-03-31 Claus E Dr Med Lange Topical care products or pharmaceuticals containing fine-particle transparent zinc oxide
WO1999059538A1 (en) * 1998-05-21 1999-11-25 The Boots Company Plc Topical composition
US6221403B1 (en) * 1992-08-08 2001-04-24 Seton Healthcare Group Plc Topical composition
WO2003051378A2 (en) * 2001-12-14 2003-06-26 Montoie Import-Export S.A. Pharmaceutical composition for topical treatment of skin disorders and skin wounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512978A (en) * 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
US6221403B1 (en) * 1992-08-08 2001-04-24 Seton Healthcare Group Plc Topical composition
DE4232143A1 (en) * 1992-09-25 1994-03-31 Claus E Dr Med Lange Topical care products or pharmaceuticals containing fine-particle transparent zinc oxide
WO1999059538A1 (en) * 1998-05-21 1999-11-25 The Boots Company Plc Topical composition
WO2003051378A2 (en) * 2001-12-14 2003-06-26 Montoie Import-Export S.A. Pharmaceutical composition for topical treatment of skin disorders and skin wounds

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Definitions of topical dosage forms", INTERNET ARTICLE, 12 February 2003 (2003-02-12), pages 1, XP002318840, Retrieved from the Internet <URL:http://www.fda.gov/ohrms/dockets/ac/03/briefing/3926B1_01_F-FDA-Definitions%20of%20Dosage%20Forms%202-12-03.htm> [retrieved on 20050223] *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; January 2001 (2001-01-01), GLOOR M ET AL: "Do shake lotions, zinc oil and polyethylene glycol gels produce dehydration or moisturization?", Database accession no. NLM11174089 *
GLOOR M ET AL: "Do shake lotions, zinc oil and polyethylene glycol gels produce dehydration or moisturization?", SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY. 2001 JAN-FEB, vol. 14, no. 1, January 2001 (2001-01-01), pages 34 - 43, XP008043521, ISSN: 1422-2868 *

Also Published As

Publication number Publication date
WO2006032464A2 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
ES2387804T3 (en) Methods of administration a dermatological agent to a subject
WO2007120868A3 (en) Bioavailability enhancement of lipophilic drug by use solvent system
WO2006037116A3 (en) Semi-solid delivery vehicle and pharmaceutical compositions
WO2002091999A3 (en) Treatment for wounds
WO2000044367A3 (en) A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
WO2009109613A3 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
JP2004507496A5 (en)
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
AU2003243719A1 (en) Topical administration of pharmacologically active bases in the treatment of warts
WO2003073981A3 (en) Novel of cytokine inhibitors
WO2006093784A3 (en) Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
PL1799186T3 (en) Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases
BR0009186A (en) Asian and madecassic acid salts suitable for the preparation of pharmaceutical and cosmetic compositions
WO2007149366B1 (en) Prolonged improvement of renal function comprising infrequent administration of an aa1ra
BRPI0715361B8 (en) use of polyethylene glycol in inflammation related to topical diseases or disorders and wound healing
WO2005123192A3 (en) Improving pain treatment with strontium combinations
WO2006032464A3 (en) Method of treatment of acute exudative skin lesions and composition useful therefor
EP1798234A4 (en) Pharmaceutical composition comprising temozolomide ester
ATE249820T1 (en) PREPARATION FOR WARTS
WO2010048365A3 (en) Therapeutic peptide bioconjugates
WO2006026604A3 (en) Methods for promoting wound healing
AR030660A1 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF AN ILLNESS ASSOCIATED WITH AN EXCESS OF IL-12 PRODUCTION
WO2006026172A3 (en) Use of soluble cd26 as inhibitor of angiogenesis and inflammation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase